Intracellular Effect of Imidazoline Receptor on α2A- Noradrenergic Receptor

Annals of the New York Academy of Sciences

Volumn 1009, Issue , 2003, Pages 427-438

  Chen, Michael J ^a   Zhu, He ^b   Piletz, John E ^c  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c JACKSON STATE UNIVERSITY   (United States)

Author keywords

Alpha2 adrenoceptor; Coincidence detection; Imidazoline receptors; IRAS; Nischarin

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE RECEPTOR ANTISERA SELECTED PROTEIN; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; BAY REGION BINDING SITE; BINDING AFFINITY; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC CODE; IMMUNOBLOTTING; MEMBRANE BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 1342347761     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1304.057     Document Type: Conference Paper

References (46)

1. BOUSQUET, P., J. FELDMAN, E. TIBIRICA, et al. 1989. New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors." Am. J. Med. 87: 10S-13S.
2. PILETZ, J.E., A. HALARIS & P.R. ERNSBERGER. 1994. Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression. Crit. Rev. Neurobiol. 9: 29-66.
3. ERNSBERGER, P., M.E. GRAVES, L.M. GRAFF, et al. 1995. I1-Imidazoline receptors: definition, characterization, distribution and transmembrane signalling. Ann. N. Y. Acad. Sci. 763: 22-42.
4. MOLDERINGS, G.J. 1997. Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy. Drugs of the Future 22: 757-772.
5. ERNSBERGER, P. & M.A. HAXHIU. 1997. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. Am. J. Physiol. 42: R1572-R1579.
6. ALTMAN, J.D., A.U. TRENDELENBURG, L. MACMILLAN, et al. 1999. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol. Pharmacol. 56: 154-161.
7. HEAD, G.A. 1999. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents. Ann. N. Y. Acad. Sci. 881: 279-286.
8. REIS, D.J. 1996. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors. J. Cardiovasc. Pharmacol. 27(Suppl 3): S11-S18.
9. RUIZ-ORTEGA, J.A., L. UGEDO, J. PINEDA, et al. 1995. The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin. Naunyn Schmiedeberg's Arch. Pharmacol. 352: 121-126.
10. ZHU, H., I.A. PAUL, D.E. STEC, et al. 2003. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses in mice. Brain Res. 964: 9-20.
11. ERNSBERGER, P., Y.R. KOU & N.R. PRABHAKAR. 1998. Carotid body I1-imidazoline receptors: binding, visualization and modulatory function. Respir. Physiol. 112: 239-251.
12. TSOLI, E., S.L. CHAN & N.G. MORGAN. 1995. The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans. Eur. J. Pharmacol. 284: 199-203.
13. ROSEN, P., P. OHLY & H. GLEICHMANN. 1997. Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat. J. Hypertens. Suppl. 15: S31-S38.
14. SANO, H., S.C. LIU, W.S. LANE, et al. 2002. Insulin receptor substrate 4 associates with the protein IRAS. J. Biol. Chem. 23: 23.
15. SMYTH, D.D. & S.B. PENNER. 1998. Imidazoline receptor mediated natriuresis: central and/or peripheral effect? J. Auton. Nerv. Sys. 72: 155-162.
16. KONNERTH, A., R. TSIEN, K. MIKOSHIBA, et al. 1996. Coincidence Detection in the Nervous System: 175. Human Frontiers Science Program. Strasbourg. France.
17. SCHLICKER, E. & M. GÖTHERT. 1998. Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res. Bull. 47: 129-132.
18. LIU, F., Q. WAN, Z.B. PRISTUPA, et al. 2000. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403: 274-280.
19. LOPES, L.V., R.A. CUNHA & J.A. RIBEIRO. 1999. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J. Neurophysiol. 82: 3196-3203.
20. CIRUELA, F., M. ESCRICHE, J. BURGUENO, et al. 2001. Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J. Biol. Chem. 276: 18345-18351.
21. MAYFIELD, R.D., B.A. JONES, H.A. MILLER, et al. 1999. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia. Synapse 33: 274-281.
22. BUDD, D.C., R.A. CHALLISS, K.W. YOUNG, et al. 1999. Cross talk between m3-muscarinic and beta(2)-adrenergic receptors at the level of receptor phosphorylation and desensitization. Mol. Pharmacol. 56: 813-823.
23. ROCHEVILLE, M., D.C. LANGE, U. KUMAR, et al. 2000. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288: 154-157.
24. LEZCANO, N., L. MRZLJAK, S. EUBANKS, et al. 2000. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287: 1660-1664.
25. BRUBAN, V., J. FELDMAN, H. GRENEY, et al. 2001. Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs. Br. J. Pharmacol. 133: 261-266.
26. COTECCHIA, S., B.K. KOBILKA, K.W. DANIEL, et al. 1990. Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells. J. Biol. Chem. 265: 63-69.
27. PILETZ, J.E., T.R. IVANOV, J.D. SHARP, et al. 2000. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol. 19: 319-329.
28. IVANOV, T.R., H. ZHU, S. REGUNATHAN, et al. 1998. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem. Pharmacol. 55: 649-655.
29. KUROSE, H., J.L. ARRIZA & R.J. LEFKOWITZ. 1993. Characterization of alpha-2-adrenergic receptor subtype-specific antibodies. Mol. Pharmacol. 43: 444-450.
30. PILETZ, J.E., H. ZHU, G. ORDWAY, et al. 2000. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol. Psychiatry 48: 910-919.
31. PILETZ, J.E. & K. SLETTEN. 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
32. BUCCAFUSCO, J.J. 1992. Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters. In International Review of Neurobiology: 55-107. Academic Press, San Diego, CA.
33. PILETZ, J.E., J.C. JONES, H. ZHU, et al. 1999. Imidazoline receptor antisera-selected cDNA clone and mRNA distribution. Ann. N. Y. Acad. Sci. 881: 1-7.
34. ORDENER, C., H. GRENEY, J. DEVEDJIAN, et al. 1999. Transfected cells expressing the three subtypes of alpha 2-adrenergic receptors lack I1-imidazoline binding sites. Ann. N. Y. Acad. Sci. 881: 59-60.
35. PILETZ, J.E., A.C. ANDORN, J.R. UNNERSTALL, et al. 1991. Binding of [3H]-p-aminoclonidine to a2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochem. Pharmacol. 42: 569-584.
36. IVANOV, T.R., Y. FENG, H. WANG, et al. 1998. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J. Psychiatr. Res. 32: 65-79.
37. MOLDERINGS, G.J., H. BONISCH, R. HAMMERMANN, et al. 2002. Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int. 40: 157-167.
38. ERNSBERGER, P., R. GIULIANO, R.N. WILLETTE, et al. 1990. Role of imidazole receptors in the vasopressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253: 408-418.
39. TOLENTINO-SILVA, F.P., M.A. HAXHIU, S. WALDBAUM, et al. 2000. Alpha(2) adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice. Brain Res. 862: 26-35.
40. FUDER, H. & P. SCHWARZ. 1993. Desensitization of inhibitory prejunctional alpha 2-adrenoceptors and putative imidazoline receptors on rabbit heart sympathetic nerves. Naunyn Schmiedeberg's Arch. Pharmacol. 348: 127-133.
41. GÖTHERT, M. & G.J. MOLDERINGS. 1991. Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn Schmiedeberg's Arch. Pharmacol. 343: 271-282.
42. GÖTHERT, M., G.J. MOLDERINGS, K. FINK, et al. 1995. Alpha 2-adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurons. Ann. N. Y. Acad. Sci. 763: 405-419.
43. PILETZ, J.E. & A. HALARIS. 1995. Involvement of I1-imidazoline receptors in mood disorders. Ann. N. Y. Acad. Sci. 763: 510-519.
44. PILETZ, J.E., G.A. ORDWAY, H. ZHU, et al. 2000. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha2-adrenergic receptors in human brain. Neuropsychopharmacology 23: 697-708.
45. PILETZ, J.E., M. ANDREW, H. ZHU, et al. 1998. Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. J. Psychiatr. Res. 32: 55-64.
46. HEAD, G.A., C.K.S. CHAN & S.L. BURKE. 1998. Relationship between imidazoline and α2-adrenoreceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J. Auton. Nerv. Sys. 72: 163-169.